<DOC>
	<DOCNO>NCT01013350</DOCNO>
	<brief_summary>Prospective Observational Long-term Safety Registry Multiple Sclerosis Patients Have Participated Cladribine Clinical Trials</brief_summary>
	<brief_title>Prospective Observational Long-term Safety Registry Multiple Sclerosis Patients Who Have Participated Cladribine Clinical Trials</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cladribine</mesh_term>
	<criteria>Prior enrollment select oral cladribine clinical trial randomization either study drug placebo , participation clinical trial end Written informed consent give Subjects reach telephone Subjects unable answer registry questionnaire next kin caregiver able answer registry questionnaires Subjects either lag interval subsequently enter interventional study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Cladribine</keyword>
	<keyword>PREMIERE</keyword>
	<keyword>Observational study</keyword>
</DOC>